Spain
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Spain (ES)
| 2000 | 2.0 million |
| 2011 | 2.8 million |
| 2024 | 4.7 million |
| 2050 | 4.9 million |
Spain is one of the 60 countries and territories in the IDF Europe Region. Spain has the fifth highest number of adults (20-79 years) with diabetes in the Region.
Data source(s) used for the diabetes estimates in adults:
- F. Soriguer, A. Goday, A. Bosch-Comas, E et al. Diabetologia. 2012 Jan;55(1):88-93. doi: 10.1007/s00125-011-2336-9. PMID: 21987347.
- Rey MJL, Garcia MD Endocrinol Diabetes Nutr (Engl Ed). 2018 Nov;65(9):515-523. doi: 10.1016/j.endinu.2018.06.006.PMID:30078493
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 2,018.3 | 2,840.1 | 4,660.2 | 4,908.0 |
| Age-standardised prevalence of diabetes, % | - | 6.3 | 9.7 | 11.4 |
| Proportion of people with undiagnosed diabetes, % | - | - | 35.5 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 1,652.0 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 2,334.0 | 2,249.0 |
| Age-standardised prevalence of IFG, % | - | - | 5.5 | 6.0 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 2,747.0 | 2,978.4 | 2,928.3 |
| Age-standardised prevalence of IGT, % | - | 6.8 | 7.1 | 7.7 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 19,518.0 | 22,125.1 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 13.7 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 127,202.4 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 37.6 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 2,093.0 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 3,811.2 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 13,089.9 | 11,189.5 |
| Total diabetes-related health expenditure, ID million | - | - | 17,109.0 | 14,625.2 |
| Diabetes-related health expenditure per person, USD | - | 3,319.0 | 2,808.9 | 2,279.9 |
| Diabetes-related health expenditure per person, ID | - | - | 3,671.3 | 2,979.9 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 189,078.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 18,660.6 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 29,899.0 | 34,895.6 | 35,645.7 | 31,243.7 |
| Population of children and adolescents (0-19 y) | - | - | 8,750,431.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 2,018.3 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 29,899.0 |
| Population of children and adolescents (0-19 y) | - |
